Azacitidine front-line in 339 patients with myelodysplastic syndromes and acute myeloid leukaemia: comparison of French-American-British and World Health Organization classifications
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Azacitidine front-line in 339 patients with myelodysplastic syndromes and acute myeloid leukaemia: comparison of French-American-British and World Health Organization classifications
Authors
Keywords
AML, MDS, WHO, FAB, Classification, RAEB-t, Bone marrow blast count, Azacitidine, Austrian Azacitidine Registry
Journal
Journal of Hematology & Oncology
Volume 9, Issue 1, Pages -
Publisher
Springer Nature
Online
2016-04-16
DOI
10.1186/s13045-016-0263-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Decitabine versus best supportive care in older patients with refractory anemia with excess blasts in transformation (RAEBt) - results of a subgroup analysis of the randomized phase III study 06011 of the EORTC Leukemia Cooperative Group and German MDS Study Group (GMDSSG)
- (2015) Heiko Becker et al. ANNALS OF HEMATOLOGY
- International phase 3 study of azacitidine vs conventional care regimens in older patients with newly diagnosed AML with >30% blasts
- (2015) H. Dombret et al. BLOOD
- Impact of Chemotherapy Delay on Overall Survival for AML with IDH1/2 Mutations: A Study in Adult Chinese Patients
- (2015) Jing-Han Wang et al. PLoS One
- De novoacute myeloid leukemia with 20-29% blasts is less aggressive than acute myeloid leukemia with ≥30% blasts in older adults: a Bone Marrow Pathology Group study
- (2014) Robert Paul Hasserjian et al. AMERICAN JOURNAL OF HEMATOLOGY
- Azacitidine in 302 patients with WHO-defined acute myeloid leukemia: results from the Austrian Azacitidine Registry of the AGMT-Study Group
- (2014) Lisa Pleyer et al. ANNALS OF HEMATOLOGY
- Acute myeloid leukemia ontogeny is defined by distinct somatic mutations
- (2014) R. C. Lindsley et al. BLOOD
- Impact of chemotherapy delay on short- and long-term survival in younger and older AML patients: a Danish population-based cohort study
- (2014) L S G Østgard et al. LEUKEMIA
- Azacitidine in CMML: Matched-pair analyses of daily-life patients reveal modest effects on clinical course and survival
- (2014) Lisa Pleyer et al. LEUKEMIA RESEARCH
- Long-Term Medical Costs and Life Expectancy of Acute Myeloid Leukemia: A Probabilistic Decision Model
- (2014) Han-I Wang et al. VALUE IN HEALTH
- Azacitidine in untreated acute myeloid leukemia: A report on 149 patients
- (2013) Sylvain Thépot et al. AMERICAN JOURNAL OF HEMATOLOGY
- Time from diagnosis to intensive chemotherapy initiation does not adversely impact the outcome of patients with acute myeloid leukemia
- (2013) S. Bertoli et al. BLOOD
- Retrospective Analysis of Prognostic Factors Associated With Response and Overall Survival by Baseline Marrow Blast Percentage in Patients With Myelodysplastic Syndromes Treated With Decitabine
- (2013) Elias Jabbour et al. Clinical Lymphoma Myeloma & Leukemia
- Azacitidine in patients with WHO-defined AML – Results of 155 patients from the Austrian Azacitidine Registry of the AGMT-Study Group
- (2013) Lisa Pleyer et al. Journal of Hematology & Oncology
- Azacitidine results in comparable outcome in newly diagnosed AML patients with more or less than 30% bone marrow blasts
- (2013) L.H. van der Helm et al. LEUKEMIA RESEARCH
- Epigenetic therapy is associated with similar survival compared with intensive chemotherapy in older patients with newly diagnosed acute myeloid leukemia
- (2012) A. Quintas-Cardama et al. BLOOD
- Revised International Prognostic Scoring System for Myelodysplastic Syndromes
- (2012) P. L. Greenberg et al. BLOOD
- Clofarabine plus low-dose cytarabine followed by clofarabine plus low-dose cytarabine alternating with decitabine in acute myeloid leukemia frontline therapy for older patients
- (2012) Stefan Faderl et al. CANCER
- Prognostic Factors Associated With Disease Progression and Overall Survival in Patients With Myelodysplastic Syndromes Treated With Decitabine
- (2012) Elias Jabbour et al. Clinical Lymphoma Myeloma & Leukemia
- Transfusion independence and survival in patients with acute myeloid leukemia treated with 5-azacytidine
- (2012) M. Gavillet et al. HAEMATOLOGICA
- Sequential azacitidine plus lenalidomide combination for elderly patients with untreated acute myeloid leukemia
- (2012) D. A. Pollyea et al. HAEMATOLOGICA
- Survival for older patients with acute myeloid leukemia: a population-based study
- (2012) B. Oran et al. HAEMATOLOGICA
- Multicenter, Randomized, Open-Label, Phase III Trial of Decitabine Versus Patient Choice, With Physician Advice, of Either Supportive Care or Low-Dose Cytarabine for the Treatment of Older Patients With Newly Diagnosed Acute Myeloid Leukemia
- (2012) Hagop M. Kantarjian et al. JOURNAL OF CLINICAL ONCOLOGY
- A phase 2 study of high-dose lenalidomide as initial therapy for older patients with acute myeloid leukemia
- (2010) T. A. Fehniger et al. BLOOD
- Refractory anemia with excess of blasts: A multivariate analysis of prognostic factors in 91 patients and a simplified scoring system for predicting survival
- (2010) Agnès-Paule Guerci et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet
- (2009) H. Dohner et al. BLOOD
- Phase II Study of Clofarabine Monotherapy in Previously Untreated Older Adults With Acute Myeloid Leukemia and Unfavorable Prognostic Factors
- (2009) Hagop M. Kantarjian et al. JOURNAL OF CLINICAL ONCOLOGY
- Azacitidine Prolongs Overall Survival Compared With Conventional Care Regimens in Elderly Patients With Low Bone Marrow Blast Count Acute Myeloid Leukemia
- (2009) Pierre Fenaux et al. JOURNAL OF CLINICAL ONCOLOGY
- Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study
- (2009) Pierre Fenaux et al. LANCET ONCOLOGY
- Time from diagnosis to treatment initiation predicts survival in younger, but not older, acute myeloid leukemia patients
- (2008) M. A. Sekeres et al. BLOOD
- A randomized study of clofarabine versus clofarabine plus low-dose cytarabine as front-line therapy for patients aged 60 years and older with acute myeloid leukemia and high-risk myelodysplastic syndrome
- (2008) S. Faderl et al. BLOOD
- Analysis of prognostic factors in patients with refractory anemia with excess of blasts (RAEB) reclassified according to WHO proposal
- (2008) M. Breccia et al. LEUKEMIA RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now